Find your next favorite work.

Search results for "Blockbuster"

CJ CGV target price raised to 6,000 won as Spider-Man 4 fuels box office; Q3 profit seen at 56.4 billion won — “Strong theater performance expected in September”

CJ CGV target price raised to 6,000 won as Spider-Man 4 fuels box office; Q3 profit seen at 56.4 billion won — “Strong theater performance expected in September”

KB Securities keeps its “Hold” rating as a 2,200 billion won 4DPLEX investment eases the company’s global financial burden
“KB Securities” raised its target price for “CJ CGV” on the 7th, forecasting strong box-office performance in September while maintaining its “Hold” rating. The target price was raised to 6,000 won from 5,000 won. “CJ CGV” closed at 5,400 won in the previous trading session.
‘The King’s Man’ Showbox launches short-form label ‘Showbite,’ sets sights on 20 titles in second half

‘The King’s Man’ Showbox launches short-form label ‘Showbite,’ sets sights on 20 titles in second half

‘Taste of You’ premieres on the 11th as Showbox follows its ReelShort partnership and targets the global short-form ecosystem
Showbox, the studio behind a string of films that drew more than 10 million admissions, is making a full-scale entry into the short-form drama market. The investment and distribution company said on the 3rd that it had established ‘Showbite,’ a label dedicated to developing and producing short-form...
'The Odyssey' surpasses 9 million moviegoers in 27 days, sets all-time IMAX attendance record after 'Avatar 2'

'The Odyssey' surpasses 9 million moviegoers in 27 days, sets all-time IMAX attendance record after 'Avatar 2'

The film draws a record 941,000 IMAX viewers and prompts a push to amend the law to crack down on ticket scalping
Four years after 'Avatar 2,' foreign film rewrites box office history 'The Odyssey,' the latest film from director Christopher Nolan, surpassed 9 million cumulative moviegoers on its 27th day in theaters, the 31st, setting off a powerful box-office surge.
'Odyssey' Scalpers Charge 100,000 Won as CGV Imposes Four-Ticket Daily Limit

'Odyssey' Scalpers Charge 100,000 Won as CGV Imposes Four-Ticket Daily Limit

The restriction applies only to the Yongsan IMAX auditorium, the country's only venue with a 1.43:1 aspect ratio, as cumulative attendance surpasses 7.65 million.
IMAX scalping prices soar as CGV takes drastic step to limit ticket purchases Multiplex theater chain 'CGV' is taking direct action to stamp out the distorted scalping market surrounding director Christopher Nolan's blockbuster 'Odyssey'.
Avengers: Endgame returns with 13.93 million viewers — what will be unveiled exclusively Sept. 23?

Avengers: Endgame returns with 13.93 million viewers — what will be unveiled exclusively Sept. 23?

The special screening will include the first exclusive footage from Avengers: Doomsday and take place in an Infinity Vision-certified theater.
The triumphant return of the top-grossing foreign film in Korean history — and the arrival of a new hidden villain Marvel Studios' 'Avengers: Endgame', which set a record as the highest-grossing foreign film ever released in South Korea, is set to take over theaters once again.
Director Kim Mi-jo on ‘Gyeongju Trip,’ Korea’s Most Provocative Mainstream Film of the Year

Director Kim Mi-jo on ‘Gyeongju Trip,’ Korea’s Most Provocative Mainstream Film of the Year

Part 2
※〈Gyeongju Trip〉 Director Kim Mi-jo's interview continues from Part 1.One striking aspect of 〈Gyeongju Trip〉 is how it depicts Baek Sang-hyun, the killer (Byun Yo-han). Why did you choose not to give any backstory to the perpetrator Baek Sang-hyun and instead portray him solely as a heinous...
'Spider-Man: Brand New Day' Crosses 8 Million, Sets Franchise Box Office Record

'Spider-Man: Brand New Day' Crosses 8 Million, Sets Franchise Box Office Record

The film reaches 8.05 million admissions in 26 days, surpassing 'Far From Home' to rank No. 2 among this year's releases
Tom Holland's 'Spider-Man' sets box office record, surpassing 8.05 million admissions in 26 days - Best performance in franchise history, with a 97% CGV Egg score signaling a long theatrical run Web-slinging action rises above loneliness and reshapes the box office 'Tom Holland'-led 'Spider-Man:...
Park Chan-wook’s ‘No Other Choice’ vs. Na Hong-jin’s ‘Hope’: Who will win at 35th Buil Film Awards on Oct. 7

Park Chan-wook’s ‘No Other Choice’ vs. Na Hong-jin’s ‘Hope’: Who will win at 35th Buil Film Awards on Oct. 7

Competition for the best actor and actress awards is fierce, with Lee Byung-hun, Yoo Hae-jin and Son Ye-jin among the contenders; ceremony set for Signiel Busan on Oct. 7
35th awards ceremony to be held at Signiel Busan in Haeundae; ‘A Man Who Lives With the King,’ which topped 10 million viewers, produces two best actor nominees A head-to-head battle between two giants leading South Korea’s film industry is taking shape.
The Assassins set for Sept. 23 release, eyes Chuseok box office

The Assassins set for Sept. 23 release, eyes Chuseok box office

〈The Assassins〉 follows the investigation into the suspicions and forces behind the Aug. 15, 1974, shooting of South Korea’s first lady that shocked the nation.
〈The Assassins〉, which has drawn early attention for director Hur Jin-ho’s meticulous direction and the powerhouse performances of leading South Korean actors including Yoo Hae-jin, Park Hae-il and Lee Min-ho, has announced a Sept. 23 release and is taking aim at theaters during the Chuseok holiday.
‘Inside Men: The Birth of Villains’ (working title) — Ha Jung-woo, Ahn Bo-hyun, Park Hae-joon and Jung Sung-il cast

‘Inside Men: The Birth of Villains’ (working title) — Ha Jung-woo, Ahn Bo-hyun, Park Hae-joon and Jung Sung-il cast

The media-capital-power cartel that shook South Korea! The 30-year origin story of 〈Inside Men〉 is revealed!
〈Inside Men〉, the highest-grossing R-rated film of all time in South Korea and a box-office and critical success that won Best Picture, Best Screenplay and Best Planning at the 53rd Daejong Film Awards and Best Picture at the 37th Blue Dragon Film Awards, returns after 11 years on an even larger...